Corebridge Financial’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,642
| Closed | -$15.3K | – | 2917 |
|
|
2025
Q1 | $15.3K | Sell |
9,642
-144
| -1% | -$229 | ﹤0.01% | 2938 |
|
|
2024
Q4 | $27.7K | Buy |
9,786
+578
| +6% | +$1.64K | ﹤0.01% | 2925 |
|
|
2024
Q3 | $36K | Sell |
9,208
-56
| -0.6% | -$219 | ﹤0.01% | 2930 |
|
|
2024
Q2 | $74.3K | Buy |
+9,264
| New | +$74.3K | ﹤0.01% | 2760 |
|